SOURCE: Sancilio and Company, Inc.

Sancilio and Company, Inc.

November 17, 2010 15:18 ET

Sancilio & Company Announces the Appointment of Mr. Jeffrey P. Tuller as Vice President of Sales and Opening of Expanded Manufacturing Facilities

RIVIERA BEACH, FL--(Marketwire - November 17, 2010) - Sancilio & Company, Inc. (SCI), headquartered in Riviera Beach, Florida, announces the appointment of Mr. Jeffrey P. Tuller, M.B.A. as Executive Vice President of Sales and a member of the executive management team.

Mr. Tuller joins SCI having been the Vice President of National Accounts and Sales of The Harvard Drug Group, LLC. Prior to his career at Harvard, Mr. Tuller was the Vice President and General Manager for AmerisourceBergen Corporation and Vice President at Cardinal Health, Inc. He holds an M.B.A. degree from Western New England College and a B.S. degree from Bridgewater State College.

SCI also announces the opening of its new high speed tablet and capsule packaging facility as well as the high potency compounding and filling area for oral liquids utilizing state-of-the-art barrier isolator systems. Dr. Frederick D. Sancilio, M.S., Ph.D., President of SCI, noted: "The expansion of SCI continues with the addition of these two new facilities and the commissioning of our new laboratory in early 2012. Further expansion is planned for Q1:2012 including the addition of a second soft gelatin manufacturing area, additional compressing rooms and tablet coating facilities." 

Dr. Sancilio said: "We are very pleased to have Jeff as part of our growing team of professionals. He brings us an enormous amount of experience and strong personal relationships that will help us achieve our aggressive growth plans." He continued by saying: "I look forward to working with him as we grow our global product line of brand, generic and contract service offerings. We plan to further expand our operation in Palm Beach County, Florida, and drive our business through our made in American focus."

About Sancilio & Company, Inc.
SCI is a fully integrated specialty pharmaceutical company providing products and contract services to a global community. The company operates US FDA registered laboratories and production facilities in Palm Beach County, Florida.

Operating out of 27,000 square feet of newly completed facilities, SCI develops, produces, packages and tests sophisticated formulations of soft gelatin capsules, oral liquids, tablets and hard gelatin capsules. The company specializes in unique formulations of essential fatty acids and difficult to produce products. SCI's products are sold globally through a network of more than 10,000 retailers.